Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy
![Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy](https://www.tandfonline.com/cms/asset/549b7ddf-b54c-4142-889c-8a961be4c8e1/khvi_a_2052657_f0001_b.gif)
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210420133028153-0386:S0950268821000698:S0950268821000698_fig3.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study, Epidemiology & Infection
![](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs36000%2F36243/img/Table2.jpg)
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate v
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10719-022-10050-2/MediaObjects/10719_2022_10050_Fig3_HTML.png)
Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40121-023-00864-4/MediaObjects/40121_2023_864_Fig6_HTML.png)
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
![](https://www.tandfonline.com/cms/asset/ffb8c50e-7b50-4bff-9dd5-58f9e46708ab/khvi_a_2160600_f0002_oc.jpg)
Full article: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210420133028153-0386:S0950268821000698:S0950268821000698_fig1.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study, Epidemiology & Infection
![](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2023/nejm_2023.388.issue-21/nejmoa2214924/20230522/images/img_medium/nejmoa2214924_f0.jpeg)
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia
![](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2023/nejm_2023.388.issue-21/nejmoa2214924/20230522/images/img_medium/nejmoa2214924_f1.jpeg)
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia
![](https://www.tandfonline.com/cms/asset/039a554c-9771-4e76-abcb-b5723dc9a0a2/khvi_a_2160600_f0004_oc.jpg)
Full article: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10719-022-10050-2/MediaObjects/10719_2022_10050_Fig6_HTML.png)
Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
![](https://www.tandfonline.com/cms/asset/f8ead085-f659-4c58-a8da-e8dd08d8a856/khvi_a_1902701_f0001_b.gif)
Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label